Bayer thrombosis drug performs well in two studies
107681
An experimental thrombosis pill from   Bayer AG, seen by analysts as the German group's most important   pipeline asset, has produced promising results in two clinical   trials, researchers said on Tuesday.
468910
Biomira reports favorable Phase II test results.
768183
An experimental drug from Sanofi-Aventis, viewed as pivotal to the newly merged company's future, showed good results in the largest clinical study of the product to date.
573459
A key study of its lead drug proceeds faster than expected.
757229
Genzyme Corp. of Cambridge and German partner Bayer Schering Pharma AG said they have begun phase 3 trials of their cancer drug Campath to treat multiple sclerosis. The companies said they plan on reporting phase 2 results Oct. 14. After phase 3, they hope to seek US regulatory approval in 2011 to market the drug, also known as alemtuzumab, to ...
695475
The Tullahoma physician was pleased with the results because he was one of the doctors participating in the study. Gupta, part of the Harton Regional Medical Center&#39;s Cardiology Group, was one of 169 researchers who looked at the efficacy of the drug.
653662
A long-acting form of Bayer's blood  pressure drug Adalat prevents heart attacks and strokes in  angina patients and cuts the need for operations to treat blood  vessel blockages, a study showed on Sunday.
525921
Bayer AG&#39;s  experimental pill  rivaroxaban is significantly more effective than standard  injections of Lovenox in preventing blood clots after knee  surgery, researchers said on Sunday.
583563
a widely prescribed arthritis treatment - more than doubled patients&#39; risk of heart problems in a clinical study. The announcement, 11 weeks after Merck &amp; Co.
320147
Cancer drug shows exceptional promise as it moves toward FDA review.
766518
A study shows promising results for Novartis's COX-2 inhibitor.
91316
German drug maker Bayer AG said Tuesday that early-stage trials of an experimental cancer treatment showed no significant safety concerns when used in combination with other drugs.
401694
A drug called picotamide appears to be a more effective blood-thinner than aspirin for people with diabetes, according to an Italian study.
193595
A new study states that Bayer AG was too slow in withdrawing Baycol, a cholesterol-lowering medicine called a statin, from the market.
751523
A new addition to an already successful drug promises good results for investors.
564001
A drug being developed by Bayer AG and Onyx Pharmaceuticals Inc. shrank tumors in some liver cancer patients and temporarily stabilized the
622596
Bayer (NYSE: BAY) is the latest company to find itself in hot water over a drug recall. But as the company gears up to burnish its image, the improvement in its financial performance promises